CardioFocus

OverviewSuggest Edit

CardioFocus is dedicated to the advancement of ablation treatments for cardiac disorders. Our laser ablation research is shedding new light on therapies for atrial fibrillation.
TypePrivate
Founded1990
HQMarlborough, US
Websitecardiofocus.com

Latest Updates

Employees (est.) (Sept 2020)68(-10%)
Cybersecurity ratingAMore

Key People/Management at CardioFocus

Paul Laviolette

Paul Laviolette

Executive Chairman
Burke Barrett

Burke Barrett

Chief Executive Officer & President and Director
Rebecca Anderson

Rebecca Anderson

Vice President, Program Management
Ian Christianson

Ian Christianson

VP, Regulatory Affairs & Quality Assurance
Scott Fletcher

Scott Fletcher

VP, Finance & Administration
Jerry Melsky

Jerry Melsky

VP, Engineering
Show more

CardioFocus Office Locations

CardioFocus has an office in Marlborough
Marlborough, US (HQ)
500 Nickerson Rd #500, Marlborough
Show all (1)

CardioFocus Financials and Metrics

Summary Metrics

Founding Date

1990

CardioFocus total Funding

$186.6 m

CardioFocus latest funding size

$55 m

Time since last funding

a year ago

CardioFocus investors

CardioFocus's latest funding round in May 2019 was reported to be $55 m. In total, CardioFocus has raised $186.6 m
Show all financial metrics

CardioFocus Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

CardioFocus Online and Social Media Presence

Embed Graph

CardioFocus News and Updates

CardioFocus Announces Impressive Results From Pivotal Confirmatory Study With The Breakthrough HeartLight® X3 System

MARLBOROUGH, Mass., May 10, 2019 /PRNewswire/ -- CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for...

GPB Capital Enters into $21 Million Debt Investment in CardioFocus®

NEW YORK, June 22, 2018 /PRNewswire/ -- GPB Capital has completed a debt investment in CardioFocus® Inc., which develops and manufactures products for the treatment of irregular heartbeats and other cardiac disorders. Proceeds from the investment will help CardioFocus commercially launch...

CardioFocus Blogs

CardioFocus® Secures $55 Million In Financing

MARLBOROUGH, Mass., May 28, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the completion of a $55 million round of financing. The post CardioFocus<sup>®</sup> Secures $55 Million I…

CardioFocus® Announces Impressive Results From Pivotal Confirmatory Study With The Breakthrough HeartLight® X3 System

MARLBOROUGH, Mass., May 10, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for the treatment …

CardioFocus® Announces European CE Mark Approval Of Breakthrough HeartLight® X3 System For The Treatment Of Atrial Fibrillation

MARLBOROUGH, Mass., Mar. 25, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System. The post CardioFocus<sup>®</s…

CardioFocus® Initiates Persistent Atrial Fibrillation Study With The Breakthrough HeartLight® X3 System

MARLBOROUGH, Mass., Mar. 5, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the first enrollments in a clinical study evaluating use of the HeartLight X3 System in an early persistent AFib patie…

CardioFocus® Completes Enrollment In HeartLight® X3 Trial

MARLBOROUGH, Mass., Nov. 29, 2018 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced completed enrollment in a trial to evaluate its next-generation HeartLight® X3 Endoscopic Ablation System. The post C…
Show more

CardioFocus Frequently Asked Questions

  • When was CardioFocus founded?

    CardioFocus was founded in 1990.

  • Who are CardioFocus key executives?

    CardioFocus's key executives are Paul Laviolette, Burke Barrett and Rebecca Anderson.

  • How many employees does CardioFocus have?

    CardioFocus has 68 employees.

  • Who are CardioFocus competitors?

    Competitors of CardioFocus include AxoGen, Sofregen Medical and ProcessHQ.

  • Where is CardioFocus headquarters?

    CardioFocus headquarters is located at 500 Nickerson Rd #500, Marlborough, Marlborough.

  • Where are CardioFocus offices?

    CardioFocus has an office in Marlborough.

  • How many offices does CardioFocus have?

    CardioFocus has 1 office.